An interventional study of High flow nasal cannula and Facial mask in Diaphragm Injury and Postoperative Complications, sponsored by Università degli Studi di Ferrara. Completed at 1 site in Italy. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2023-10-24.
Sponsored by Università degli Studi di Ferrara · Not applicable, Interventional, and Prevention
Prospective randomized study investigating the effect of postoperative oxygen delivery on diaphragmatic function. Two different modalities of oxygen delivery will be compared: high flow nasal cannula versus standard oxygen therapy with facial mask
1,233 studies on the registry are indexed under Postoperative Complications; 292 are open to participants now.
This study's enrollment of 116 is close to the median of 119 across 689 interventional studies indexed under Postoperative Complications.
Browse Postoperative Complications studies →Università degli Studi di Ferrara is the lead sponsor of 64 studies on the registry; 10 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Two hours after extubation patients will received high flow nasal cannula oxygenation therapy for 24 hours
Device: High flow nasal cannula
Two hours after extubation patients will received standard oxygenation therapy for 24 hours
Device: Facial mask
A device able to delivery high flow oxygen therapy
standard oxygen therapy
Incidence of diaphragmatic dysfunction
Ultrasound evaluation of diaphragmatic dysfunction
Time frame: 24 hours after surgery
Postoperative pulmonary complication
Incidence of postoperative pulmonary complication
Time frame: 7 days after surgery
Days without oxygen support
Time frame: 7 days
Plan to share: Yes — Study dataset will be shared in anonymous form under reasonable request
Supporting information: Study protocol, Sap
No publications or documents are linked to this record.
This study is completed, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Università degli Studi di Ferrara